Search Results - "Chehrazi-Raffle, Alex"

Targeted therapies: Expanding the role of FGFR3 inhibition in urothelial carcinoma.

Authors: Zengin, Zeynep B. Chehrazi-Raffle, Alex Salgia, Nicholas J. et al.

Source: Urologic Oncology. Feb2022, Vol. 40 Issue 2, p25-36. 12p.

Assessment of eligibility criteria in renal cell carcinoma trials evaluating systemic therapy.

Authors: Castro, Daniela V. Prajapati, Sweta R. Feng, Matthew I. et al.

Source: BJU International. Mar2024, Vol. 133 Issue 3, p297-304. 8p.

Perceptions of COVID-19 Vaccination in Patients with Genitourinary Cancers: A Survey Study.

Authors: Castro, Daniela V. Zengin, Zeynep B. Malhotra, Jasnoor et al.

Source: Cancer Investigation. Jan2023, Vol. 41 Issue 1, p70-76. 7p.

Changes in Perception of Cure Among Patients With Genitourinary Cancers Initiating Immune Checkpoint Inhibitors: A Longitudinal Study.

Authors: Bergerot, Cristiane Decat Philip, Errol J. Govindarajan, Ameish et al.

Source: Clinical Genitourinary Cancer. Dec2023, Vol. 21 Issue 6, p626-630.e3. 8p.

Association Between Time-of-Day of Immune Checkpoint Blockade Administration and Outcomes in Metastatic Renal Cell Carcinoma.

Authors: Dizman, Nazli Govindarajan, Ameish Zengin, Zeynep B. et al.

Source: Clinical Genitourinary Cancer. Oct2023, Vol. 21 Issue 5, p530-536. 7p.

Comprehensive Profiling of Cell Surface Proteins in Testicular Germ Cell Tumors.

Authors: Ebrahimi H Moradi A Barragan-Carrillo R et al.

Source: Cancer research communications [Cancer Res Commun] 2026 Jul 01; Vol. 6 (7), pp. 1762-1768.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE

Feasibility and acceptability of a mindfulness app-based intervention among patients with metastatic renal cell carcinoma: a multinational study.

Authors: Bergerot CD Bergerot PG Philip EJ et al.

Source: The oncologist [Oncologist] 2025 Jan 17; Vol. 30 (1).

Publication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Darolutamide plus androgen-deprivation therapy in high-risk biochemical recurrence of prostate cancer (ARASTEP).

Authors: Morgans AK Chehrazi-Raffle A Niazi T et al.

Source: Future oncology (London, England) [Future Oncol] 2025 Nov; Vol. 21 (27), pp. 3491-3498. Date of Electronic Publication: 2025 Nov 11.

Publication Type: Journal Article; Clinical Trial Protocol

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

Assessment of Compliance With ASCO Language of Respect Guidelines in Renal Cell Carcinoma Abstracts.

Authors: Dizman N Agarwal R Castro DV et al.

Source: JCO oncology practice [JCO Oncol Pract] 2025 Nov; Vol. 21 (11), pp. 1689-1694. Date of Electronic Publication: 2025 Apr 07.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE

Twelve-Month Follow-up of the Immune Response After COVID-19 Vaccination in Patients with Genitourinary Cancers: A Prospective Cohort Analysis.

Authors: Meza L Zengin Z Salgia S et al.

Source: The oncologist [Oncologist] 2023 Sep 07; Vol. 28 (9), pp. e748-e755.

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

The impact of insurance status on progression-free survival (PFS) and overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC).

Authors: Castro, Daniela Tripathi, Nishita Sayegh, Nicolas et al.

Source: The oncologist 2023 Supplement 1; Vol. 28.

Journal Info: Publisher: Oxford University Press / USA ISSN: 1083-7159

Characterization of papillary and clear cell renal cell carcinoma through imaging mass cytometry reveals distinct immunologic profiles.

Authors: Govindarajan A Salgia NJ Li H et al.

Source: Frontiers in immunology [Front Immunol] 2023 Aug 11; Vol. 14, pp. 1182581. Date of Electronic Publication: 2023 Aug 11 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial.

Authors: Ebrahimi H Dizman N Meza L et al.

Source: Nature medicine [Nat Med] 2024 Sep; Vol. 30 (9), pp. 2576-2585. Date of Electronic Publication: 2024 Jun 28.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Racial and ethnic differences in perceptions of germline or somatic DNA sequencing among patients with advanced prostate, urothelial, or kidney cancer.

Authors: Bergerot CD Philip EJ Malhotra J et al.

Source: Journal of genetic counseling [J Genet Couns] 2024 Aug; Vol. 33 (4), pp. 911-915. Date of Electronic Publication: 2023 Sep 12.

Publication Type: Journal Article

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 9206865 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-3599 (Electronic) Linking ISSN: 10597700 NLM ISO Abbreviation: J Genet Couns Subsets: MEDLINE

Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic Therapy.

Authors: Ebrahimi H Battle D Salgia NJ et al.

Source: Nutrients [Nutrients] 2024 May 26; Vol. 16 (11). Date of Electronic Publication: 2024 May 26.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Publishing Country of Publication: Switzerland NLM ID: 101521595 Publication Model: Electronic Cited Medium: Internet ISSN: 2072-6643 (Electronic) Linking ISSN: 20726643 NLM ISO Abbreviation: Nutrients Subsets: MEDLINE

Tumor Mutational Burden in Metastatic Castration-Resistant Prostate Cancer and Response to Checkpoint Inhibition.

Authors: Zang PD Chawla NS Barragan-Carrillo R et al.

Source: JAMA oncology [JAMA Oncol] 2024 Apr 01; Vol. 10 (4), pp. 531-532.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

Boosting CAR T cells with anti-tumor mRNA vaccines.

Authors: Chehrazi-Raffle A Budde LE Pal SK

Source: Nature medicine [Nat Med] 2023 Nov; Vol. 29 (11), pp. 2711-2712.

Publication Type: Journal Article; Comment

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Unique Spectrum of Activating BRAF Alterations in Prostate Cancer.

Authors: Chehrazi-Raffle A Tukachinsky H Toye E et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Oct 02; Vol. 29 (19), pp. 3948-3957.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Genomic and Transcriptomic Predictors of Response from Stereotactic Body Radiation Therapy in Patients with Oligoprogressive Renal Cell Carcinoma.

Authors: Zengin ZB Govindarajan A Salgia N et al.

Source: European urology oncology [Eur Urol Oncol] 2023 Aug; Vol. 6 (4), pp. 447-450. Date of Electronic Publication: 2023 Jan 04.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE

Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial.

Authors: Dizman N Meza L Bergerot P et al.

Source: Nature medicine [Nat Med] 2022 Apr; Vol. 28 (4), pp. 704-712. Date of Electronic Publication: 2022 Feb 28.

Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE